Variability of risk factors and diabetes complications
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Several studies suggest that, together with glucose variability, the variability of other risk factors, as blood pressure, plasma lipids, heart rate, body weight, and serum uric acid, might play a role in the development of diabetes complications. Moreover, the variability of each risk factor, when contemporarily present, may have additive effects. However, the question is whether variability is causal or a marker. Evidence shows that the quality of care and the attainment of the target impact on the variability of all risk factors. On the other hand, for some of them causality may be considered. Although specific studies are still lacking, it should be useful checking the variability of a risk factor, together with its magnitude out of the normal range, in clinical practice. This can lead to an improvement of the quality of care, which, in turn, could further hesitate in an improvement of risk factors variability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Reduced Heart Rate Variability on Risk for Cardiac Events: The Framingham Heart Study
Tsuji, H., Larson, M. G., Venditti, F. J., Manders, E. S., Evans, J. C., Feldman, C. L., & Levy, D. (1996) · Circulation · doi:10.1161/01.cir.94.11.2850 · Cited by 1,762
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
Mahmood, S. S., Levy, D., Vasan, R. S., & Wang, T. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61752-3 · Cited by 1,622 · cited 2×
“In the same study it was also clear that the presence of diabetes contributes to amplify the additive effect of the risk factors in the development of the CV complications [45].”
BackgroundMethodGlycaemic variability in diabetes: clinical and therapeutic implications
Ceriello, A., Monnier, L., & Owens, D. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30136-0 · Cited by 588 · cited 7×
“While a number of metrics has been proposed to assess long-term variability, the most commonly used is the standard deviation (SD) of the collected values [1].”
BackgroundInfluentialSelf-citationHirakawa, Y., Arima, H., Zoungas, S., Ninomiya, T., Cooper, M., Hamet, P., Mancia, G., Poulter, N., Harrap, S., Woodward, M., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0199 · Cited by 363 · cited 1×
“Many observational [1] and some interventional studies [2], as well as post-hoc analyses of trials such as the “Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation” (ADVANCE), [3] the “Trial Comparing Cardiovascular Safety of Insulin Degludec vs.”
BackgroundDi Flaviani, A., Picconi, F., Di Stefano, P., Giordani, I., Malandrucco, I., Maggio, P., Palazzo, P., Sgreccia, F., Peraldo, C., Farina, F., et al. (2011) · Diabetes Care · doi:10.2337/dc11-0034 · Cited by 179
Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial
Zhou, J. J., Schwenke, D. C., Bahn, G., & Reaven, P. (2018) · Diabetes Care · doi:10.2337/dc18-0548 · Cited by 131 · cited 1×
“Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events” (DEVOTE), [4] the “Veterans Affairs Diabetes Trial” (VADT), [5] the “Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial” (HALLHAT), [6] the “Action to Control Cardiovascular Risk in Diabetes” (ACCORD) tria…”
BackgroundCoopmans, C., Zhou, T. L., Henry, R. M. A., Heijman, J., Schaper, N. C., Koster, A., Schram, M. T., van der Kallen, C. J. H., Wesselius, A., den Engelsman, R. J. A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2367 · Cited by 93
Ranjan, A. G., Rosenlund, S. V., Hansen, T. W., Rossing, P., Andersen, S., & Nørgaard, K. (2020) · Diabetes Care · doi:10.2337/dc20-0909 · Cited by 72 · cited 1×
“Many observational [1] and some interventional studies [2], as well as post-hoc analyses of trials such as the “Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation” (ADVANCE), [3] the “Trial Comparing Cardiovascular Safety of Insulin Degludec vs.”
Background
Cited by
Insights into the molecular underpinning of type 2 diabetes complications
Singh, A., Bocher, O., & Zeggini, E. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddae203 · Cited by 10
“Various risk factors have been linked to the occurrence of complications including hypertension, smoking, obesity, age, diabetes duration and male gender, summarized in Table 2 [3, 5, 8].”
Metadata
- Authors
- Ceriello, A., & Prattichizzo, F.
- Venue
- Cardiovascular Diabetology
- Published
- 2021-05-07
- Volume
- 20
- Issue
- 1
- Pages
- 101-101
- ISSN
- 1475-2840 (ISSN-L)
- OpenAlex
- W3159153974
- Cited by
- 167
- References
- 8
- FWCI
- 14.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Variability of risk factors and diabetes complications. https://app.cochat.ai/papers/10.1186/s12933-021-01289-4
- The paper
- Ceriello, A., & Prattichizzo, F. (2021). Variability of risk factors and diabetes complications. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-021-01289-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.